Artes Medical Asks EPO, USPTO To Revoke Patents For Sanofi-Aventis Lipoatrophy Treatment
A U.S. drug maker has asked the European Patent Office and the U.S. Patent and Trademark Office to revoke patents held by French rival Sanofi-Aventis on the dermatological treatment Sculptra....To view the full article, register now.
Already a subscriber? Click here to view full article